Building the foundations for an organized population-based cervical cancer screening program with primary HPV self-sampling in Catalonia, Spain: findings from a pilot implementation study

dc.contributor.authorPeremiquel Trillas, Paula
dc.contributor.authorRoura Fornells, Esther
dc.contributor.authorRangel Sarmiento, Valentina
dc.contributor.authorMorey, Francisca
dc.contributor.authorFont, Rebeca
dc.contributor.authorCarvajal Restoy, Maite
dc.contributor.authorRobles, Claudia
dc.contributor.authorIbáñez, Raquel
dc.contributor.authorPijuan, Lara
dc.contributor.authorTamarit, Lourdes
dc.contributor.authorCortasa, Dolça
dc.contributor.authorFernández, Daniel
dc.contributor.authorAlfons Espinàs, Josep
dc.contributor.authorBruni, Laia
dc.contributor.authorThe Catalan Cervical Cancer Screening Program Working Group
dc.date.accessioned2025-09-12T07:05:44Z
dc.date.available2025-09-12T07:05:44Z
dc.date.issued2025-08-04
dc.date.updated2025-09-10T08:12:05Z
dc.description.abstractIntroduction As part of the transition from opportunistic cytology-based screening to an organized, population-based HPV screening program, Catalonia, Spain, launched an implementation pilot in 2021.Methods The pilot combined home-based HPV self-sampling with pharmacy-based distribution, coordinated by a screening office using an SMS-based invitation and reminder system, alongside structured follow-up of HPV-positive cases by midwives.Results From July 2021 to December 2023, 6,355 women seeking cervical cancer screening were invited to participate in HPV self-sampling via SMS, with high participation (80.9%). Among HPV-positive women (11.8%), compliance with triage cytology was high (98.7%), as with colposcopy referrals when indicated (97.2%). CIN2+ detection rates (3.6% overall, 13.1% in HPV-16 positive) aligned with international studies, reinforcing the value of genotype-specific risk stratification and risk-adapted follow-up pathways in our setting. This organized approach facilitated timely case management and demonstrated the feasibility, acceptability, and effectiveness of the model.Discussion While conducted in an opportunistic screening context with a relatively short follow-up time, these findings support HPV self-sampling as an effective primary screening strategy, including women who regularly attend cervical cancer screening, and provide key insights for its scalability within a population-based program, which began its pilot phase in 2024 and is set for full implementation in 2025.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2296-858X
dc.identifier.pmid40832106
dc.identifier.urihttps://hdl.handle.net/2445/223112
dc.language.isoeng
dc.publisherFrontiers Media SA
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fmed.2025.1580665
dc.relation.ispartofFrontiers in Medicine, 2025, vol. 12
dc.relation.urihttps://doi.org/10.3389/fmed.2025.1580665
dc.rightscc-by (c) Peremiquel Trillas, Paula et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationCàncer de coll uterí
dc.subject.classificationPapil·lomavirus
dc.subject.classificationCribratge
dc.subject.otherCervix cancer
dc.subject.otherPapillomaviruses
dc.subject.otherMedical screening
dc.titleBuilding the foundations for an organized population-based cervical cancer screening program with primary HPV self-sampling in Catalonia, Spain: findings from a pilot implementation study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
fmed-4-1580665.pdf
Mida:
4.85 MB
Format:
Adobe Portable Document Format